Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia

Journal of Neurosurgery

Volumn 85, Issue 1, 1996, Pages 112-116

  Baskaya, Mustafa K ^b   Hu, Yingan ^b   Donaldson, David ^b   Maley, Mary ^b   Rao, A Muralikrishna ^b   Prasad, M Renuka ^b   Dempsey, Robert J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

cerebral blood flow; edema; gerbil; ischemia; leukotriene; lipoxygenase; reperfusion

Indexed keywords

DOCEBENONE; LEUKOTRIENE C4; LIPOXYGENASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN EDEMA; CONTROLLED STUDY; GERBIL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RELATIVE DENSITY; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK;

EID: 0030012931     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.1.0112     Document Type: Article

References (33)

1. Abe K, Kogure K, Yamamoto H, et al: Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J Neurochem 48:503-509, 1987
2. Aktan S, Aykut B, Yegen BC, et al: Prostaglandin E2 and leukotriene C4 levels following different reperfusion periods in rat brain correlated with morphological changes. Prostaglandins Leukot Essent Fatty Acids 46:287-290, 1992
3. Baba T, Black KL, Ikezaki K, et al: Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab 11:638-643, 1991
4. Bazán NG Jr: Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218:1-10, 1970
5. Black KL, Hoff JT: Leukotrienes and blood brain barrier permeability. J Cereb Blood Flow Metab 5 (Suppl):S263-S264, 1985
6. Black KL, Hoff JT: Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats. Ann Neurol 18:349-351, 1985
7. 4 on cerebral arteries of newborn pigs. Pediatr Res 20:973-976, 1986
8. Chandler MJ, De Leo J, Carney JM: An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J Pharmacol Methods 14:137-146, 1985
9. Dempsey RJ, Roy MW, Cowen DE, et al: Lipoxygenase metabolites of arachidonic acid and the development of ischaemic cerebral oedema. Neurol Res 8: 53-56, 1986
10. Dempsey RJ, Roy MW, Meyer K, et al: Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg 64: 118-124, 1986
11. Gaudet RJ, Alam I, Levine L: Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem 35:653-658, 1980
12. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994-2998, 1975
13. Higgs GA, Flower RJ, Vane JR: A new approach to anti-inflammatory drugs. Biochem Pharmacol 28:1959-1961, 1979
14. Humes JL, Sadowski S, Galavage M, et al: Pharmacological effects of non-steroidal antiinflammatory agents on prostaglandin and leukotriene synthesis in mouse peritoneal macrophages. Biochem Pharmacol 32:2319-2322, 1983
15. Ikeda M, Yoshida S, Busto R, et al: Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J Neurochem 47:123-132, 1986
16. Kamitani T, Little MH, Ellis EF: Effects of leukotrienes, 12-HETE, histamine, bradykinin, and 5-hydroxytryptamine on in vivo rabbit cerebral arteriolar diameter. J Cereb Blood Flow Metab 5:554-559, 1985
17. 2 and C activation during ischemia. J Neurochem 61:1677-1684, 1993
18. Kindy MS, Hu Y, Dempsey RJ: Blockade of ornithine decarboxylase enzyme protects against ischemic brain damage. J Cereb Blood Flow Metab 14:1040-1045, 1994
19. Mabe H, Nagai H, Suzuka T: Role of brain tissue leukotriene in brain oedema following cerebral ischaemia: effect of a 5-lipoxygenase inhibitor, AA-861. Neurol Res 12:165-168, 1990
20. Marcoux FW, Goodrich JE, Dominick MA: Ketamine prevents ischemic neuronal injury. Brain Res 452:329-335, 1988
21. 4 as a possible cause of cerebral edema. Stroke 19:372-377, 1988
22. 4 in gerbil brains after ischemia and reperfusion. Science 224:886-889, 1984
23. Nakano S, Kogure K, Abe K, et al: Ischemia-induced alterations in lipid metabolism of the gerbil cerebral cortex: I. Changes in free fatty acid liberation. J Neurochem 54:1911-1916, 1990
24. Patel PM, Drummond JC, Mitchell MD, et al: Eicosanoid production in the caudate nucleus and dorsal hippocampus after forebrain ischemia: a microdialysis study. J Cereb Blood Flow Metab 12:88-95, 1992
25. Rådmark O, Malmsten C, Samuelsson B: The inhibitory effects of BW 755C on arachidonic acid metabolism in human polymorphonuclear leukocytes. FEBS Lett 110:213-215, 1980
26. Robak J, Duniec Z: The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities. Biochem Pharmacol 31:1955-1959, 1982
27. Samuelsson B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568-575, 1983
28. Tzigaret C, McIntosh TK, Okiyama K, et al: Measurement of hippocampal levels of cellular second messengers following in situ freezing. J Neurochem 60:827-834, 1993
29. 4. Prostaglandins 21:637-648, 1981
30. Unterberg A, Schmidt W, Wahl M, et al: Evidence against leukotrienes as mediators of brain edema. J Neurosurg 74: 773-780, 1991
31. Wahl M, Unterberg A, Baethmann A, et al: Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 8:621-634, 1988
32. Wolfe LS, Coceani F: The role of prostaglandins in the central nervous system. Annu Rev Physiol 41:669-684, 1979
33. Yoshida S, Ikeda M, Busto R, et al: Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J Neurochem 47:744-757, 1986